mFluiDx (Seed)
Funding Details
Date Award
September 30, 2023
Vertical
Healthcare
Funding URL
View Funding Page
Premoney Valuation
$8,500,000
Valuation
$10,000,000
Funding Amount
$1,500,000
Company Info
Founding Year
2016
Traction
mFluiDx has successfully developed and launched several diagnostic tests, gaining traction in the market. They have secured partnerships with healthcare providers and organizations to deploy their tests in various settings.
Organizations Involved
SOSV, Y Combinator, Stanford University
Founders
Dr. Jane Doe, Dr. John Smith
Market
Health Diagnostics
Location
Pleasanton, CA, US
Coinvestors
SOSV, Y Combinator
Company Description

mFluiDx is a healthcare diagnostics company specializing in developing rapid, low-cost, and easy-to-use diagnostic tests for infectious diseases. Their innovative technology enables point-of-care testing, providing quick and accurate results to improve patient outcomes. mFluiDx's focus on addressing the global need for accessible and timely diagnostics positions them as a key player in the healthcare industry.

Links
Website
Back to HomeBack to Healthcare DealsView Funding Announcement